Transcell Oncologics Private Limited, a amalgamated private limited company, was established on 02 August 2017 in Hyderabad, Telangana, India. Engaging in research & development within the professional, scientific and technical sector, it holds CIN: U74999TG2017PTC118680. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.15 M and a paid-up capital of ₹0.13 M.
It upholds a compliant status. Its leadership includes Uday Chatterjee (Director), Vinayender Tulla (Director), Subhadra Dravida (Director). Past directors included Uday Chatterjee. It holds no open charges and ₹2.70 M settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 8Th Floor Western Pearl, Kondapur, Hyderabad, Telangana, 500084.
U74999TG2017PTC118680
118680
02 August 2017
₹0.15 M
₹0.13 M
Roc Hyderabad
Unlisted
Amalgamated
Explore comprehensive insights into Transcell Oncologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Uday Chatterjee | Director | 05 Jul 2021 | Current |
| Vinayender Tulla | Director | 02 Aug 2017 | Current |
| Subhadra Dravida | Director | 02 Aug 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Transcell Oncologics Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 29.63% decrease. The company also saw a slight improvement in profitability, with a 9.71% increase in profit. The company's net worth observed a substantial decline by a decrease of 30.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Transcell Oncologics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹2,700,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jul 2021 | Hdfc Bank Limited | ₹2.70 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Transcell Oncologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Transcell Oncologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Transcell Oncologics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 08 Jul 2021 via Charge ID 100470061 with Hdfc Bank Limited was fully satisfied on 13 Oct 2023. was recorded as a recent event.
Progress on Transcell Oncologics Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
The activity Transcell Oncologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 2.70 M with Charge ID 100470061 was registered on 08 Jul 2021. was recorded as a recent event.
Progress on Uday Chatterjee was appointed as a Director was appointed as a Director on 05 Jul 2021 & has been associated with this company since 4 years 4 months . was documented.
Progress on Vinayender Tulla was appointed as a Director was appointed as a Director on 02 Aug 2017 & has been associated with this company since 8 years 3 months . was documented.
The CIN of Transcell Oncologics Private Limited is U74999TG2017PTC118680.
Transcell Oncologics Private Limited is headquartered at 8Th Floor Western Pearl, Kondapur, Hyderabad, Telangana, 500084.
Transcell Oncologics Private Limited was incorporated on 02 August 2017.
The current directors of Transcell Oncologics Private Limited are
The primary industry of Transcell Oncologics Private Limited is Professional, Scientific And Technical.
Transcell Oncologics Private Limited is unlisted.
The authorized capital of Transcell Oncologics Private Limited is ₹0.15 M, and the paid-up capital is ₹0.13 M.
The compliance status of Transcell Oncologics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX